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Abstract
Peg3 (paternally expressed gene 3) is an imprinted gene encoding a DNA-binding protein. This gene plays important roles in
controlling fetal growth rates and nurturing behaviors. In the current study, a new mutant mouse model has been
generated to further characterize the functions of this DNA-binding protein. Besides known phenotypes, this new mutant
model also revealed potential roles of Peg3 in mammalian reproduction. Female heterozygotes produce a much smaller
number of mature oocytes than the wild-type littermates, resulting in reduced litter sizes. According to genome-wide
expression analyses, several placenta-specific gene families are de-repressed in the brain of Peg3 heterozygous embryos,
including prolactin, cathepsin and carcinoembryonic antigen cell adhesion molecule (Ceacam) families. The observed derepression is more pronounced in females than in males. The de-repression of several members of these gene families is
observed even in the adult brain, suggesting potential defects in epigenetic setting of the placenta-specific gene families in
the Peg3 mutants. Overall, these results indicate that Peg3 likely controls the transcription of several placenta-specific gene
families, and further suggest that this predicted transcriptional control by Peg3 might be mediated through unknown
epigenetic mechanisms.
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[17],[19]. Thus, PEG3 has been often regarded as a potential
tumor suppressor in humans.
PEG3 is known to interact with several key proteins for various
cellular processes. First, PEG3 interacts with TRAF2 (TNF
receptor-associated factor 2), which controls the TNF (tumor
necrosis factor) responsive pathway by activating NF-kB (NFkappa-B) [20]. Second, PEG3 also interacts with SIAH1A (E3
ubiquitin-protein ligase SIAH1A), and this interaction triggers the
induction of p53-mediated apoptosis in various cell lineages [21].
Consistent with this, several environmental insults, including
hypoxic conditions, are known to up-regulate both PEG3 and p53
in cell lines as well as animal models, suggesting that Peg3 may be a
downstream gene for the p53-dependent apoptosis pathway [22].
Third, PEG3 is also known to inhibit the Wnt signaling pathway
by promoting b-catenin degradation [23]. Lately, Peg3 (also known
as Pw1) has been recognized as a gene marker for myogenic
progenitor cells based on the demonstration that a population of
PW1-positive cells can regenerate skeletal muscle [24],[25].
Besides these various roles at the cellular level, recent studies
using ChIP (Chromatin ImmunoPrecipitation) also revealed
potential protein functions of PEG3 [26]. According to the results,
PEG3 binds to specific genomic regions as a DNA-binding
protein. Subsequently, many genomic loci have been identified as
potential downstream targets for PEG3. Follow-up studies further
demonstrated that PEG3 functions as a repressor in the
transcription of these potential downstream genes [26].

Introduction
Peg3 (paternally expressed gene 3) is an imprinted gene located
in proximal mouse chromosome 7/human chromosome 19q13.4
[1–3]. The genomic interval surrounding this gene is filled with
lineage-specific Kruppel-type zinc finger genes [3]. Peg3 itself is
thought to have been derived from this type of ZNFs based on the
presence of 12 zinc finger motifs within its ORF (Open Reading
Frame) [1–3]. Peg3 is placenta mammal-specific: the homologues
are found only within eutherian mammals, but not in other
mammals, such as metatherian and monotremes [4]. According to
earlier studies on a mutant mouse line targeting Peg3, this gene is
involved in controlling milk ‘letdown’ processes and nurturing
behaviors in females [5],[6]. Later studies demonstrated that this
gene also controls adipocyte differentiation and sexual behaviors in
males [7],[8]. The imprinting of Peg3 is regulated through a 4-kb
CpG island surrounding its 1st exon, termed the Peg3-DMR
(Differentially Methylated Region) [9]. The Peg3-DMR contains
multiple YY1 binding sites [10]. YY1 has subsequently been
implicated in establishment and/or maintenance of the allelespecific DNA methylation at the Peg3-DMR [11–13]. In humans,
the PEG3-DMR is known to be an epigenetically susceptible
region: many patients of ovarian, breast and glioma cancers tend
to lose the expression of PEG3 mainly due to DNA hypermethylation on the PEG3-DMR [14–19]. Interestingly, reintroducing
PEG3 into primary cell lines derived from these cancer patients
inhibited cell growth, demonstrating tumor suppressor activity
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the first inheriting the targeted allele paternally (+/2p) with gene
dosage of Peg3 being null whereas the second inheriting the
targeted allele maternally (2m/+) with the gene dosage being
normal. Thus, this study used four different breeding schemes with
the two types of heterozygous males and females (Fig. 2). The first
set of breeding schemes (1 and 2) bred male and female
heterozygotes (+/2p) with their wild-type littermates. The second
set of breeding schemes (3 and 4) bred male and female
heterozygotes (2m/+) with their wild-type littermates. The pups
derived from these breeding were genotyped, and their body
weights were measured and converted into percentile scores as an
indicator for their health status. The results derived from these
breeding experiments are as follows. The litter sizes (6.89 and 5.63)
of the first set of breeding experiments (Breeding 1 and 2) were
much smaller than the litter sizes (9.12 and 9.66) of the second set
of breeding experiments (Breeding 3 and 4) (Fig. 2). Statistical
significance of the observed differences are as follows: the p-value
is 0.033 for Student t-Test between Breeding 1 versus 3 while the
p-value is 0 for Breeding 2 versus 4. Yet, the ratios of
heterozygotes to wild-types were all close to the mendelian ratio
of 1:1 among the pups derived from the 4 different breeding
schemes. This indicates no lethality associated with the targeted
allele during embryonic development. This further suggests that
the small litter sizes observed from Breeding 1 and 2 might be
caused by unknown mutational effects of the targeted allele on the
heterozygous parents (+/2p). It is important to note that the gene
dosage of Peg3 is null in these heterozygous parents in contrast to
the normal dosage of the heterozygous parents in Breeding 3 and
4.
To further follow up the prediction, we examined the
morphology of reproductive organs harvested from the heterozygotes (+/2p), and counted the number of germ cells derived from
the heterozygotes. There were no major morphological defects in
the reproductive organs of male and female heterozygotes except
the testes of the heterozygote males were visually smaller than
those of the wild-type littermates. The size difference of the testes
between the heterozygotes and wild-types was proportional to
their body weight differences, suggesting that the smaller-size testes
might be an outcome of the overall growth retardation observed in
the heterozygotes, which will be described later. On the other
hand, the number of mature oocytes found in the heterozygote
females (average 5 oocytes per ovary, n = 6) was much smaller
than the numbers from the wild-type littermates (average 10
oocytes per ovary, n = 6). This might be consistent with the small
litter sizes observed in Breeding 2 with the heterozygous females.
In contrast, the number of sperm was highly variable between
individual adult mice, thus no statistically significant conclusion
could be reached regarding the potential impact of the mutant
allele of Peg3 on the number of sperm. Overall, a series of breeding
experiments concluded that the observed small litter sizes are likely
caused by Peg3’s mutational impact on the reproductive system of
the breeding mice, thus suggesting potential roles of Peg3 in
mammalian reproduction.

Despite earlier studies, there are still many knowledge gaps
between the known functions of Peg3 at different levels. For
instance, although PEG3 is regarded as a DNA-binding protein at
the molecular level, it is unclear how this DNA-binding protein is
involved in controlling animal behaviors and growth rates at the
organismal level. To further characterize the functions of Peg3, we
have generated a new mutant mouse model in the current study.
This new model has been used for performing a series of breeding
and expression analyses. The results indicate that Peg3 may play
important roles in mammalian reproduction. Also, genome-wide
expression analyses indicate that several placenta-specific gene
families are de-repressed in the brain of Peg3-heterozygous
embryos and adults. This study further suggests that Peg3 is
involved in the transcriptional control of these placenta-specific
gene families.

Results
Generation of a new mutant allele
A new mutant allele for Peg3 was generated using a targeted ES
cell (Peg3tm1a(EUCOMM)hmgu), which was obtained from the
EUCOMM (European Conditional Mouse Mutagenesis program)
[27]. In this ES clone, the 5th intron of Peg3 has been targeted by
the insertion of a 7.1-kb cassette containing the promoterless LacZ
gene and the neomycin resistance gene driven by the human bactin promoter (Fig. 1A). This cassette was inserted through
homologous recombination using two hooks: a 5.0-kb genomic
region encompassing exon 3–5 and a 4.9-kb genomic fragment
encompassing exons 6–8 and part of exon 9. The proper targeting
was confirmed by long-distance PCR (Fig. 1B). The targeted ES
clone (C57BL/6-derived JM8.N4 with the C/C genotype, black
coat color) was injected into blastocysts that were harvested from
albino females (C57BL/6 with the c/c genotype). This injection
produced five chimeras with varying degrees of black coat color
contribution ranging from 60 to 100%. Out of these five chimeras,
two were successful in breeding with C57BL/6N females,
generating 14 F1 mice out of 20 litters with germline transmission
of the targeted allele. However, only 6 pups (2 males and 4
females) survived to the adulthood whereas the remaining 8 pups
were dead on their first day.
The high level of perinatal lethality at the F1 generation was
expected, since the gene dosage of Peg3 is already null among the
F1 pups with the target allele. In these F1 animals, the maternal
allele of Peg3 is silenced due to the imprinting-driven DNA
methylation on the Peg3-DMR. On the other hand, the paternal
transmission of the targeted allele is designed to truncate the
transcription of Peg3 through the two poly(A) signals that have
been included as part of the inserted cassette (Fig. 1A). To further
confirm this predicted truncation, we performed RT-PCR
analyses using total RNA derived from F1 with paternal
transmission of the targeted allele (Fig. 1C). The results indicated
almost complete truncation of Peg3 transcription. This was further
confirmed with western blotting, showing no detectible levels of
the PEG3 protein in the F1 mice (Fig. 1D). Collectively, the
results described above confirm the successful generation of a new
mutant allele for the Peg3 locus. In this new mutant allele, the
inserted cassette truncates transcription of Peg3, resulting in no
detectible levels of the PEG3 protein.

Mutational effects on milk provision and growth rates
The pups derived from the four breeding schemes were also
analyzed to detect potential mutational effects on growth-related
phenotypes during early neonatal stages (postnatal day 1 through
7). Monitoring the pups derived two major conclusions. First, half
of the heterozygotes (+/2p) from Breeding 1 and 3 died during
this stage mainly because they were outcompeted for milk by the
littermates. To reduce this competition, the litter size from these
breeding schemes has been often maintained smaller than 5, which
has been an effective approach for securing the survival of the

Mutational effects on litter sizes
With the newly derived mutant line, we performed several series
of breeding experiments to characterize potential mutational
effects of the targeted allele at the organismal level. Since the Peg3
locus is imprinted, the heterozygotes can be divided into two types:
PLOS ONE | www.plosone.org
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Figure 1. Exon structure and targeting scheme of the Peg3 locus. (A) Schematic representations of the genomic locus of mouse Peg3 and the
targeting vector. The 9 exons of Peg3 are indicated with vertical lines. The targeting vector is made of a negative selection marker (DTA, Diphtheria
Toxin A), an insertion cassette and two homology hooks. The relative positions of two homology hooks are shown along with the genomic structure
of Peg3 with dotted lines. The 7.1-kb insertion cassette contains promoterless galactosidase (b-Gal) and human b-actin promoter-driven neomycin
resistance gene (Neo). The bottom panel shows the relative positions of PCR primers with small arrows and the predicted sizes of genomic and RTPCR products. (B) Genomic LD (Long Distance)-PCR. Two different sets of primers successfully amplified 6.7-kb genomic fragments from the genomic
DNA of a heterozygote animal (KO), but not from that of a wild-type littermate (WT), confirming the proper targeting of the insertion cassette. (C) RTPCR. RT-PCR was performed using the total RNA from WT and KO animals. The two primer sets (b-actin and 1a/1b) amplified similar levels of products
between KO and WT, but the third primer set (1a/1c) flanking the insertion cassette amplified only from WT, confirming the proper truncation of Peg3
transcription in KO. (D) Western blot analyses using the protein extracts prepared from the neonatal brains of WT and KO. This analysis revealed the
absence of PEG3 protein in the pup inheriting the KO allele paternally.
doi:10.1371/journal.pone.0083359.g001

heterozygotes (+/2p). In retrospect, this may have been a major
reason for high levels of the perinatal lethality observed during the
derivation of F1 mice with the germline transmission from the
chimeras. To further test this possibility, we scored each pup based
on the size of a milk spot on postnatal day 1: no milk spot with an
empty stomach, and small, medium and large milk spots (crescent, half- and full-size oval-shaped stomachs in Fig. 3). More than
half of the heterozygotes from Breeding 1 and 3 had no milk spot
with an empty stomach. In contrast, the pups derived from
Breeding 4 did not show any correlation between the genotype
and the size of milk spot, confirming that the maternal
transmission of the targeted allele has no impact due to the
genomic imprinting-driven repression of the targeted allele.
Statistical significances of these observations are as follows: the
size of milk spot versus the genotype (X2 test, df = 1, p = 0.0225)
and the size of milk spot versus the mode of transmission (X2 test,
df = 1, p = 0.0004). The pups from Breeding 2 were not included
for this analysis mainly because their litter size was usually too
small, although the entire litter of pups from Breeding 2 often had
no milk spot. Overall, these observations indicate that some
problems associated with milk suckling are likely the major cause
for perinatal lethality observed among the heterozygotes (+/2p)
derived from the breeding.

PLOS ONE | www.plosone.org

Second, besides the observed perinatal lethality, the growth of
the heterozygotes with the paternal transmission was overall
retarded throughout the neonatal to weaning stages (Fig. 4).
According to the average weight percentiles of the 1-day-old pups,
the heterozygotes (+/2p) from Breeding 1 and 3 showed about
10% smaller body weight than their wild-type littermates
(Student’s t-Test, p = 0.0003 for females and p = 0.01 for males)
(Fig. 4A). In contrast, the heterozygotes (2m/+) from Breeding 2
and 4 did not show any difference compared to those of the wildtype littermates (Student’s t-Test, p = 0.53 for females and p = 0.33
for males). The individual pups from these breeding schemes also
displayed quite different weight profiles between the paternal and
maternal transmission (Fig. 4C&D). In the paternal transmission,
the peak of weight profile for the heterozygotes is around 90–
100%, which is 15% smaller than the peak of the wild-type
littermates (105–115%) (Fig. 4C). In the maternal transmission,
the weight profiles were almost identical between the heterozygotes and wild-type littermates (Fig. 4D). We also followed up the
initial patterns of growth-related effects through monitoring the
weights of weaning-age mice (Postnatal day 21) (Fig. 4B). The
mice from the maternal transmission did not show any difference
between the heterozygotes and wild-type littermates (data not
shown). However, the mice from the paternal transmission
displayed 24–29% weight difference between the heterozygotes
3
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survey on these adult mice further confirmed that this weight
difference between the two genotypes was sustained throughout
the lifetime of the mice. Overall, these results indicate that the
mutant allele on Peg3 causes perinatal lethality through unknown
problems associated with milk provision. Also, the mutation has a
major impact on the growth rates of the mice throughout their
lifetime.

Mutational effects on gene expression in embryo head
and placenta
We decided to perform genome-wide expression analyses to
further understand the observed mutational effects described
above. For this series of experiments, one litter of 14.5-dpc (days
post coitum) fetuses were obtained through timed mating between
a male heterozygote (2m/+) and wild-type female littermate. The
gender and genotype of each fetus were first determined with PCR
using DNA isolated from the amnionic sac. Since Peg3 is highly
expressed in brain and placenta, total RNA was isolated from
embryo heads and placenta. This series of experiments analyzed
individually each total RNA that had been isolated from 8 sample
sets of embryo heads and placenta, representing 4 heterozygotes
(+/2p) and wild-types, including 4 males and females. The results
derived from this series of experiments are as follows. First, the
expression levels of a large number of genes are affected in the
embryo heads of the heterozygotes: 325 genes displayed upregulation (.1.5-fold) whereas 162 genes showed down-regulation
(,1.5-fold). In placenta, the expression levels of a larger number of
genes are also affected: 489 and 378 genes show up- and downregulation, respectively (Material S1&S2). Second, gene-clustering analyses using the affected genes indicate that many genes of
the affected genes can be grouped into several biological pathways

Figure 2. Mutational effects on the litter size of the mouse. Two
different types of heterozygotes were used for breeding experiments:
males and females inheriting the mutant allele paternally (+/2P) versus
maternally (2m/+). Due to genomic imprinting, the gene dosage of
Peg3 is almost null in the first type (Breeding 1 and 2) whereas the gene
dosage in the second type is normal (Breeding 3 and 4). The average
litter sizes and the ratios of genotypes (KO versus WT) were shown for
the four sets of breeding experiments. The numbers inside parentheses
indicate the sizes of individual litters.
doi:10.1371/journal.pone.0083359.g002

and wild-type littermate in both genders (Student’s t-Test,
p = 0.0002 for females and p = 0.012 for males). Our continued

Figure 3. Mutational effects on milk suckling. The pictures on left show one-day-old pups with their stomachs filled with milk (white milk spot).
A large fraction of the heterozygotes inheriting the mutant allele paternally (A) do not show milk spots as tabulated with a graph on right. On the
other hand, the heterozygotes with maternal transmission of the mutant allele (B) do not show any correlation between their genotypes and
phenotypes (milk spot), since the maternal allele is already silenced by genomic imprinting.
doi:10.1371/journal.pone.0083359.g003

PLOS ONE | www.plosone.org
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Figure 4. Mutational effects on growth rates. One-day-old pups derived from the four different breeding schemes detailed in Fig. 2 were also
analyzed in terms of their birth weight percentiles. Birth weight percentiles were calculated through dividing the weight of each pup by the average
weight of the litter. The weight profiles of two genotypes (WT versus KO) were presented for each group either with the paternal (C) or maternal (D)
transmission. The pups inheriting the KO allele paternally showed smaller body weights than their littermates. The values on the X-axis indicate
percentile scores, while the values on the Y-axis indicate the number of mice. The overall averages of weight percentiles for these two groups were
also compared between the two genders of mice (A). The weight profiles of some of these pups were further analyzed similarly at the weaning age
(B).
doi:10.1371/journal.pone.0083359.g004

(Fig. 5, Fig. S1, Material S2). Among the various pathways,
two pathways are the most frequently observed in this series of
clustering analyses, lipid metabolism and fatty acid processes
(Fig. 5). This is also consistent with the previous observation that
Peg3 plays significant roles in adipocyte differentiation and control
of growth rates [7].
According to manual inspection of the list of affected genes, the
expression levels of two groups of genes were most affected in the
embryo head by the mutation. One group includes many genes
that are involved in lipid metabolism, such as Clec2d (C-type lectin
domain family 2 member D), S3–12, Cidea (cell death activator
CIDE-A), Cidec (cell death activator CIDE-C) and Pparg (peroxisome proliferator-activated receptor gamma). This is again
consistent with the fact that Peg3 is involved in adipocyte
differentiation. The other group includes members of placentaspecific gene families, such as prolactin (Prl3b1 and Prl2b1),
cathepsin (Ctsj and Ctsq) and carcinoembryonic antigen cell
adhesion molecule (Ceacam 11 and 12). The observed changes in
the expression levels of these gene families were always upregulation. Interestingly, the levels of up-regulation were much
greater in females (30-fold) than in males (5-fold) (Fig. 6A). The
changes in these families were more readily detectible since these
gene families are not normally expressed at all in the embryo head.
In placenta, on the other hand, there was no major difference in
the expression levels of these gene families between the wild-types
and heterozygotes (Fig. 6A). In conclusion, a large number of
PLOS ONE | www.plosone.org

genes are affected in the mutant mice in terms of their expression
levels. Among the affected genes, the most dramatic changes were
observed in several placenta-specific gene families, suggesting that
Peg3 might be involved in the transcriptional control of these gene
families.

Mutational effects on the transcription of placentaspecific gene families
We further analyzed the up-regulation of several placentaspecific gene families observed in the embryo heads of the
heterozygotes using the total RNA isolated from different-stage
brains, 14.5-dpc embryos, neonates and adults. For this series of
analyses, total RNA was isolated from the brains of the wild-types
and heterozygotes (+/2p) with two different genders (Fig. 6B).
According to the results from independent RT-PCR analyses, the
members of the three placenta-specific gene families are indeed
up-regulated in the embryo head, consistent with the initial results
derived from genome-wide expression analyses (Fig. 6A). The
confirmed up-regulation was also much higher in females than in
males. We also analyzed the total RNA isolated from neonate
brains (Fig. S2). Two genes (Ctsj and Prl3b1) were up-regulated in
the brains of 1-day-old heterozygotes. At this stage, however, the
up-regulation was not obvious in males, but was easily detectible in
females, displaying 15- and 30-fold up-regulation for Ctsj and
Prl3b1, respectively. We also performed RT-PCR analyses using

5
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Figure 5. Mutational effects on global gene expression. A litter of 14.5-dpc fetuses were prepared from a crossing of a heterozygote male
(2m/+) and wild-type female. Global gene expression analyses were performed with a set of total 8 embryo heads and placenta representing one of
the following four combinations: male hetetrozygote and wild-type and female heteterozygote and wild-type. This series of expression analyses
identified four groups of genes: up- and down-regulated gene sets for embryo head and placenta. These four groups of genes were used for
identifying enriched pathways using the bioinformatics program EGAN (Explorative Gene Association Networks). Two of these four results are shown:
enriched pathways with up-regulated genes at 14.5-dpc embryo heads (A) and placenta (B). The remaining two results showing enriched pathways
with down-regulated genes at both samples are shown in Fig. S1. The annotation for the diagrams is as follow. Lines: Dark Purple, Human proteinprotein interactions; Light Purple, PubMed co-occurrence (literature); Gold, All protein-protein interactions; Grey, Chromosomal sequence (proximity);
Red, GO Function, transcription regulator activity; Green, GO Process, generation of neurons. Circles: Red (color gradient), up-regulated genes; darker
red signifying higher WT:KO expression ratio.
doi:10.1371/journal.pone.0083359.g005

the total RNA isolated from the pituitary glands of 6-month-old
female mice. This series of analyses also confirmed the upregulation of Ctsj and Ctsq in the heterozygotes (Fig. S2).
However, the up-regulation of the other gene families, Prl and
Ceacam, could not be determined due to the overall low expression
levels. Besides these gene families, we also analyzed the expression
levels of several other genes, including Clec2d, S3–12, Cidec, Pparg,
Esr1 (estrogen receptor alpha) and Oxtr (oxytocin receptor)
(Fig. 6B). Among these genes, the up-regulation was further
confirmed for the three genes (Clec2d, S3–12 and Cidec), which are
involved in lipid metabolism. In conclusion, this series of
expression analyses confirmed the up-regulation of placentaspecific gene families in different-stage mouse brains. Since these
gene families are expressed mainly in placenta during the gestation
period, the observed up-regulation is thought to be an outcome of
global de-repression of these gene families in the brains of neonatal
and adult mice.

Discussion
In the current study, a new mutant mouse model has been
generated to further characterize the in vivo functions of the
imprinted gene Peg3. The results from breeding experiments
indicated potential roles for Peg3 in mammalian reproduction:
females heterozygous for the mutant allele produce a much smaller
number of mature oocytes, resulting in reduced litter sizes
compared to those of wild-type littermates. The results also
revealed partial neonatal lethality among the heterozygotes (+/2p)
mainly because the heterozygotes are outcompeted for milk by the
wild-type littermates. Genome-wide expression analyses indicated
the two types of genes most affected by the Peg3 mutation: the first
group being those involved in lipid metabolism and the second
group being the members of placenta-specific gene families
(prolactin, cathepsin, ceacam). Detailed analyses further indicated
that the observed up-regulation of these gene families might be an
outcome of de-repression of these placenta-specific gene families in
the brain of the Peg3 mutant mice. Overall, these results suggest
that Peg3 may be involved in transcriptional regulation of these
placenta-specific gene families.

Figure 6. Mutational effects on placenta-specific gene families. The expression levels of three placenta-specific gene families (Cts, Prl,
Ceacam) were not affected in placenta (left heat map), but up-regulated in the embryo head of the heterozygotes (right heat map)(A). The observed
up-regulation of these gene families was further analyzed with RT-PCR using total RNA isolated from the 14.5-dpc embryo heads of the wild-type
(WT) and heterozygote embryos (KO) with two different sexes, male (M), female (F)(B). The name of each gene analyzed is indicated on the left side of
the gel image showing the PCR products.
doi:10.1371/journal.pone.0083359.g006
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The results from breeding experiments clearly indicate potential
roles for Peg3 in mammalian reproduction (Fig. 2). The
heterozygotes with the paternally transmitted mutant allele
(Breeding 1 and 2) tend to have much smaller litter sizes than
those with the maternally transmitted mutant allele (Breeding 3
and 4). Yet, the genotypes of the offspring from these 4 breeding
schemes are all close to the mendelian ratio of 1 to 1 between the
mutant allele carriers and wild-types, suggesting no embryonic
lethality associated with these breeding experiments. The two
types of heterozygotes used for these breeding experiments are
quite different from each other in terms of Peg3’s gene dosage due
to genomic imprinting (Fig. 2). The gene dosage of Peg3 is almost
null in the heterozygotes with paternal transmission (+/2P)
whereas the dosage is normal in those with maternal transmission
(2m/+). It is also important to note that mammalian Peg3 is highly
expressed in the two reproductive organs, testis and ovary,
suggesting major roles in reproduction [3]. Thus, the small litter
sizes may be caused by some unknown defects in the reproductive
system of the heterozygotes with paternal transmission. Consistent
with this prediction, female heterozygotes (+/2P) produce much
smaller numbers of mature oocytes than the wild-type littermates.
It is not obvious at the moment how the mutation on Peg3 results
in reduction in the number of mature oocytes since Peg3 function
has not been well studied in the mammalian reproductive system.
This is also the case for the other imprinted genes, although
genomic imprinting is closely tied to mammalian reproduction
[28]. Thus, it would be of great interest to further investigate
potential roles of Peg3 in the mammalian reproductive system in
the near future.
According to the results from genome-wide expression analyses,
the expression levels of many genes are affected in embryo heads
and placenta by the Peg3 mutation (Fig. 5&6). Among the many
affected genes, the mutational effects on three placenta-specific
gene families are unique based on the following reasons. First, the
mutational effects on these gene families are all up-regulation.
These gene families are expressed mainly in placenta, but not in
embryos [29],[30]. Yet, these gene families are all up-regulated in
the brains of the mutant embryos. Second, the mutational effects
appear to be global. Each of these gene families occupies relatively
large genomic intervals, size-ranging from 0.5 to 2 Mb genomic
distance [29]. Detailed examination indicated that the majority of
members in each gene family are affected by the Peg3 mutation
(Fig. 6). Third, the mutational effects are also somewhat
permanent, not temporary, as the observed up-regulation is
detected in embryo heads as well as in neonatal and adult brains
(Fig. S2). These patterns of up-regulation suggest that some
unknown setting for the repression of these gene families might not
be properly established in the Peg3 mutant mice. According to the
results from the ENCODE project [31], these gene families are
marked with the H3K9me3 modification (trimethylation at lysine
9 of histone 3) in the majority of embryonic and adult tissues, but
not in placenta where these gene families are highly expressed. In
placenta, these gene families are marked with active histone marks,
such as H3K27ac and H3K4me3. The H3K9me3 is a well-known
repression signal for many gene families, especially for tissuespecific gene families [32]. Thus, it is reasonable to predict that the
observed up-regulation might be an outcome of defects in
H3K9me3 or H3K9me3-related epigenetic settings in the Peg3
mutant mice. It is also interesting to note that Peg3 encodes a
transcriptional repressor with DNA-binding capability [26], but it
is unclear whether the repression activity of PEG3 is also mediated
through H3K9me3. Nevertheless, the observed up-regulation
suggests a potential functional connection of Peg3 to the epigenetic
setting of the three placenta-specific gene families.
PLOS ONE | www.plosone.org

Genome-wide expression analyses also revealed a previously
uncharacterized aspect of the Peg3 locus, a sexually biased effect by
the Peg3 mutation. The observed up-regulation of the placentaspecific gene families is much more obvious in females than in
males (Fig. 6). This sexually biased effect by the Peg3 mutation
appears to be reminiscent of several independent observations
associated with the Peg3 locus. First, according to the results from
previous breeding experiments with a mutant strain deleting part
of the Peg3-DMR, the deletion affects the survival and growth
rates of males more severely than females [9]. Second, nutritional
studies also indicate that the expression levels of Peg3 are more
easily affected in males than in females by mal-nutrition during the
gestation period [33]. Third, many reported disease cases
associated with the human PEG3 locus also tend to be sexually
biased. Hypermethylation on the PEG3-DMR has been detected
mainly in female-specific cancers, such as ovarian and breast
cancers [15],[17],[18]. Along with the sexually biased mutational
effect observed in the current study, these independent observations strongly suggest that the functions of Peg3 might be closely
connected to, or influenced by, mammalian sexual differentiation.
Peg3 is also highly expressed in a known sexually dimorphic part of
brain, the hypothalamus, further supporting the potential connection of Peg3 function to mammalian sexual differentiation [28]. In
conclusion, although these independent observations need to be
further investigated more thoroughly, it becomes more obvious
that Peg3 function is intertwined with mammalian sexual
differentiation.
In summary, the current study reports the successful derivation
of a new mutant model for Peg3. The current study also reports
three new observations regarding the in vivo roles of Peg3: defects in
reproduction, perinatal lethality, and ectopic expression of
placenta-specific gene families in brains. These observations have
never been reported previously, thus providing new insights
regarding the in vivo roles of Peg3. We further highlighted the
significance of these observations by comparing with the previous
observations that have been derived from another mutant model
of Peg3 (Table 1). There are some similarities and differences
between the two mutant models. Peg3’s roles in controlling milk
provision and growth rates are reproducible. In contrast, Peg3’s
roles in reproduction have not been noticed earlier from another
mutant model, which may need further investigation in the near
future. Overall, the new mutant model described in the current
study should be very useful for further investigating the in vivo roles
of Peg3.

Materials and Methods
Ethics Statement
All the experiments related to mice were performed in
accordance with National Institutes of Health guidelines for care
and use of animals, and also approved by the Louisiana State
University Institutional Animal Care and Use Committee
(IACUC), protocol #10-071.

Generation of a new mutant allele for Peg3
A targeted ES cell (Peg3tm1aEUCOMMhmgu) was obtained from
EUCOMM, and the DNA isolated from this ES cell was further
analyzed using a long-distance PCR scheme with the following
primer set: GF3 (59- GCCAATATCCAACTCATGCTACGTTC-39) and LAR3 (59-CAACGGGTTCTTCTGTTAGTCC-39);
RAF5
(59-CACACCTCCCCCTGAACCTGAAAC-39)
and
GR3
(59GTTGTTGCTGGTAGTTGAGCGTTGTC-39). After the confirmation, this ES cell was microinjected into the blastocyst of e3.58
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Table 1. Comparison of phenotypes derived from the two different mutant models of Peg3.

1. Mutagenesis method

Previous studies (Ref. No. 5 & 6)

Current study

Targeted knockin at Exon 5 followed by transcription
truncation

Targeted knockin at Intron 5 followed by transcription
truncation

2. Genetic background

129sv

C57BL6/N

3. Mutational effect on
litter sizes

1) Paternal transmission Control:Mutant = 6.86:5.96

1) Paternal transmission Control:Mutant = 9.12:6.89

2) Maternal transmission Control:Mutant = 6.86:6.46

2) Maternal transmission Control:Mutant = 9.66:5.63

4. Mutational effect on
reproduction

Not available.

Female Peg3+/2 heterozygotes have a reduced
number of mature oocytes.

5. Mutational effects on
lethality

Not available.

Perinatal lethal for Peg3+/2 pups - half of the mutant
pups die during the Postnatal day 1 through 3.

6. Mutational effects on milk
provision and growth rates

Female Peg3+/2 heterozygotes have defects in nurturing
and milk letdown.

Heterozygous Peg3+/2 pups have a milk-suckling problem.

7. Mutational effects at the
molecular and cellular levels

Female Peg3+/2 heterozygotes have a reduced number of
oxytocin neurons.

Female Peg3+/2 heterozygotes have ectopic expression of
placenta-specific gene families in brains.

doi:10.1371/journal.pone.0083359.t001

was further treated with DNAse I and later purified with columns
to remove any genomic contaminations (Qiagen, RNeasy Minikit). Each total RNA (2 mg) was used for generating labeled cRNA
for hybridization on a mouse expression analysis platform
(Illumina, Microarray-Mouse Ref-8 v2 expression beadchip). In
brief, each cRNA sample (750 ng) was hybridized onto the
expression bead chips at 58uC overnight. Chips were scanned with
the Illumina Bead Array Reader (Factor = 1, PMT 520,
Filter = 100%), and the numeric results were extracted with
GenomeStudio using the Gene Expression Module v.1.0.6. Raw
data were background-subtracted and normalized using the
quantile normalization method (lumi software package)
[34],[35]. Normalized data were filtered for genes with significant
expression levels compared to negative control beads. Selection for
differentially expressed genes was performed on the basis of
arbitrary thresholds for fold changes plus statistical significance
according to the Illumina t-test error model (limma software) [36].
The mRNA array data in MIAME compliant has been submitted
to the NCBI Gene Expression Omnibus (GEO) database
(Accession No. GSE50818). Pathway analyses were also performed with the EGAN (Explorative Gene Association Networks)
package with the obtained gene sets with up- and down-regulation
[37].

embryos of C57BL/6J (albino mice with the c/c genotype).
Among the five chimeras obtained from the injection, two were
successfully bred with female breeders of the C57BL/6N origin
(black mice with the C/C genotype), producing 6 live F1 with the
germline transmission of the targeted allele. These 6 F1 have been
used for establishing the mutant line.

Mouse breeding
Two different types of heterozygotes were prepared for breeding
experiment: male and female heterozygotes carrying the paternally
(+/2p) and maternally (2m/+) transmitted targeted allele. These 4
heterozygotes were bred with their littermates: for Breeding 1,
female wild-type littermates6male heterozygotes (+/2P); Breeding
2, female heterozygotes (+/2P)6male wild-type littermates;
Breeding 3, female wild-type littermates6male heterozygotes
(2m/+); for Breeding 4, female heterozygotes (2m/+)6male
wild-type littermates. One-day-old pups derived from these
breeding were genotyped using the following primer set: Peg35arm (59-CCCTCAGCAGAGCTGTTTCCTGCC-39) and
LAR3 (59-CAACGGGTTCTTCTGTTAGTCC-39). The genders of these pups were determined using the following primer set:
mSry-F (5-GTCCCGTGGTGAGAGGCACAAG-3) and mSry-R
(5-GCAGCTCTACTCCAGTCTTGCC-3). The body weights of
the pups were also measured as an indicator for their health status.
For genotyping and gender determination, genomic DNA was
isolated from either clipped tails or ears by incubating the tissues
overnight at 55uC in the lysis buffer (0.1 M Tris-Cl, pH 8.8, 5 mM
EDTA, pH 8.0, 0.2% SDS, 0.2 M NaCl, 20 mg/ml Proteinase K).

Quantitative RT-PCR analyses
Total RNA was isolated from the brains of neonates and adults
using a commercial kit (Trizol, Invitrogen). The isolated RNA was
first reverse-transcribed using the SuperScript III First-Strand
Synthesis System (Invitrogen), and the subsequent cDNA was used
as a template for quantitative real-time PCR. This analysis was
performed with the iQ SYBR green supermix (Bio-Rad) using the
iCycler iQTM multicolor real-time detection system (Bio-Rad). All
qRT-PCR reactions were carried out for 40 cycles under standard
PCR conditions. The results derived from qRT-PCR were further
analyzed as described previously [11]. The information regarding
individual primer sequences and PCR conditions is also available
(Material S3).

Genome-wide expression analysis
A litter of 14.5-dpc fetuses were harvested from a timed mating
between a male heterozygote (2m/+) and wild-type female
littermate. Three tissues were obtained from each fetus: embryo
head, placenta and amnionic sac. The DNA from amnionic sac
was used for determining the genotype and gender of each fetus.
Embryo heads and placenta were used for isolating total RNA.
Total 16 samples were used for this series of genome-wide
expression analyses: 8 embryo heads and placenta representing
two biological replicates of each of the four following combinations: male wild-type, male heterozygote, female wild-type, and
female heterozygote. The isolated total RNA from each sample
PLOS ONE | www.plosone.org

Western blot
Neonatal mouse brain tissues were isolated and homogenized in
cooled T-PER Protein Extraction Reagent (Pierce) with Proteinase
9
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RNA isolated from 1-day-old brains (A) and also pituitary glands
of 6-month-old females (B).
(TIFF)

Inhibitor Cocktail Set I (Calbiochem) added in accordance with
manufacturer’s protocol. Cellular debris was removed by centrifugation for 10 minutes. Protein concentrations were determined
by the Bradford assay kit (Thermo Scientific). 66Loading dye was
then added and fifty micrograms of lysate were separated on 10%
SDS–PAGE gels then transferred to PVDF membranes (HybondP, Amersham) using a Mini Trans-Blot transfer cell (Bio-Rad).
Membranes were blocked for 1 hour in the Tris-buffered saline
with 0.05% Tween-20 (TBS-T) containing 1% BLOT Quick
Blocker Reagent (Calbiochem), and incubated at 4uC overnight
with custom-made anti-PEG3 primary antibody [12]. Membranes
were then washed multiple times at room temperature in TBS-T
and incubated for an additional 1 hour with anti-rabbit secondary
antibody linked to horseradish peroxidase (Sigma). Blots were
washed and exposed to ECL (Thermo Scientific) and developed
against x-ray film.

Material S1 Lists of genes that are up- and down-regulated at
14.5-dpc embryo heads and placenta by the Peg3 mutation.
(XLSX)
Material S2 Lists of biological pathways in which the up- and
down-regulated genes by the Peg3 mutation are clustered.
(XLSX)
Material S3

List of primers that were used for qRT-PCR.

(XLSX)
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